The European Medicines Agency (EMA) on Wednesday released draft versions of the third revision to its good pharmacovigilance practice (GVP) module XVI guideline on risk minimization measures and its ...

Key market opportunities include developing comprehensive risk-based pharmacovigilance (PV) audit strategies aligned with EMA and FDA guidelines. Focus areas involve designing PV audit plans, risk ...

The European Medicines Agency (EMA) on Wednesday released its recently adopted guideline on good pharmacovigilance practices (GVP) module providing recommendations for pharmacovigilance in pediatric ...

Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "Advanced Pharmacovigilance Auditing and Inspections Course" training has been added to ResearchAndMarkets.com's offering. PV Audit Strategy Planning ...

The European Medicines Agency (“EMA”) has released a guidance document for assessors. The guidance document is written in a questions-and-answers form. It should be read in combination with the ...

The EMA Good Pharmacovigilance Practices consist of several chapters of the Notice to Applicants that are regularly updated. A new GVP Considerations Chapter (IV) regarding specific considerations for ...

The European Medicines Agency has published its first set of finalized guidelines concerning good pharmacovigilance practices. The European Medicines Agency (EMA) has published its first set of ...

The agency has revised its good pharmacovigilance practices guide on risk management systems. The European Medicines Agency (EMA) has revised module V of the good pharmacovigilance practices (GVP) on ...

DUBLIN--(BUSINESS WIRE)--The "Advanced Pharmacovigilance Auditing and Inspections Course" training has been added to ResearchAndMarkets.com's offering. This two-day workshop conference will review the ...